Dang Q D, Di Cera E
Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis 63110.
J Protein Chem. 1994 May;13(4):367-73. doi: 10.1007/BF01901692.
Cloning of the thrombin cDNA has made it possible to study thrombin function by site-directed mutagenesis. Quantitative results from studies of thrombin mutants are often hindered by difficulties in assaying the enzyme activity. The high enzyme concentrations required for activity determination by standard methods limit their usefulness to thrombin mutants that cannot be readily produced in large quantities. We have developed a novel method using the synthetic substrate S-2238 and hirudin, a tight-binding inhibitor of thrombin, that allows for the active-site titration of thrombin at concentrations as low as 20 pM, with an error of < or = 5%. In addition, hirudin activity can be determined by this method to concentrations as low as 40 pM, with an error of < or = 5%.
凝血酶cDNA的克隆使得通过定点诱变研究凝血酶功能成为可能。凝血酶突变体研究的定量结果常常因酶活性测定的困难而受到阻碍。通过标准方法测定活性所需的高酶浓度限制了它们对难以大量制备的凝血酶突变体的实用性。我们开发了一种使用合成底物S-2238和水蛭素(一种凝血酶紧密结合抑制剂)的新方法,该方法能够在低至20 pM的浓度下对凝血酶进行活性位点滴定,误差≤5%。此外,用该方法可测定低至40 pM浓度的水蛭素活性,误差≤5%。